Published in Int J Gynaecol Obstet on March 01, 1999
Developing and pre-testing a decision board to facilitate informed choice about delivery approach in uncomplicated pregnancy. BMC Pregnancy Childbirth (2009) 0.82
Cesarean delivery on maternal request: can the ethical problem be solved by the principlist approach? BMC Med Ethics (2008) 0.80
Impact of Alternative Maternal Demand-Side Financial Support Programs in India on the Caesarean Section Rates: Indications of Supplier-Induced Demand. Matern Child Health J (2016) 0.78
Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol (1994) 2.93
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol (1996) 2.21
Is Adam worth more than Eve? The financial impact of gender bias in the federal reimbursement of gynecological procedures. Gynecol Oncol (1997) 1.41
Gynecologic radiotherapy fields defined by intraoperative measurements. Gynecol Oncol (1990) 1.28
Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trial. Am J Obstet Gynecol (1994) 0.93
Prognostic factors in adenocarcinoma of the uterine cervix. Cancer (1986) 0.90
Bowel complications with taxol therapy. J Clin Oncol (1993) 0.86
Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. Am J Obstet Gynecol (1988) 0.86
Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract. Gynecol Oncol (1987) 0.84
The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma. Gynecol Oncol (1996) 0.83
A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer. Gynecol Oncol (1997) 0.83
Glassy cell carcinoma of the cervix redefined. Obstet Gynecol (1988) 0.83
The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer. Gynecol Oncol (1992) 0.80
Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancy. Gynecol Oncol (1994) 0.80
Stage IB adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am J Obstet Gynecol (1989) 0.80
Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol (1997) 0.79
Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancy. Gynecol Oncol (1989) 0.78
The use of intraoperative radiation therapy in radical salvage for recurrent cervical cancer: outcome and toxicity. Am J Obstet Gynecol (1995) 0.78
Comparison of 1997 Medicare relative value units for gender-specific procedures: is Adam still worth more than Eve? Gynecol Oncol (1997) 0.77
Adjunctive hysterectomy following radiation therapy for bulky carcinoma of the uterine cervix: prognostic implications of tumor persistence. Gynecol Oncol (1987) 0.77
Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary. Gynecol Oncol (1992) 0.76
Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study. Gynecol Oncol (1983) 0.76
A review of second-look laparotomy for ovarian cancer. Gynecol Oncol (1986) 0.76
Screening for cervical cancer. Science (2000) 0.75
The ethics of pain management for cancer patients: case studies and analysis. J Pain Symptom Manage (1994) 0.75
International Medical Ethics: The FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health. Int J Gynaecol Obstet (2004) 0.75
Triploid fetus and hydatidiform mole: antenatal diagnosis and cytogenetic study. Gynecol Oncol (1982) 0.75
Reviving the pelvic examination for evaluating the status of ovarian carcinoma. J Clin Oncol (1995) 0.75
Supraumbilical upper abdominal midline incision for pelvic surgery in the morbidly obese patient. Obstet Gynecol (1990) 0.75
Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemma. Am J Obstet Gynecol (1990) 0.75
High dose para-aortic lymph node irradiation for gynecologic cancer: technique, toxicity, and results. Int J Radiat Oncol Biol Phys (1987) 0.75
Intraoperative electron beam therapy. Radiol Med (1990) 0.75
The ethical and medical consequences of violence against women. Int J Gynaecol Obstet (1996) 0.75
The utility of immunocytochemistry in invasive adenocarcinoma of the cervix. Am J Obstet Gynecol (1992) 0.75
Women's health: we are only at the foothills. Curr Womens Health Rep (2001) 0.75
Primary chemotherapy and the role of second-look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary. Gynecol Oncol (1988) 0.75